Smith SC, 2011, Circulation, 124, 2458, 10.1161/CIR.0b013e318235eb4d
Gurbel PA, 2010, Circulation, 121, 569, 10.1161/CIRCULATIONAHA.109.853085
Rapsomaniki E, 2016, Eur Heart J Qual Care Clin Outcomes, 2, 172, 10.1093/ehjqcco/qcw004
Özcan C, 2018, Eur Heart J Cardiovasc Pharmacother, 4, 25, 10.1093/ehjcvp/pvx009
Cipollone F, 2005, Arterioscler Thromb Vasc Biol, 25, 1665, 10.1161/01.ATV.0000172632.96987.2d
Peters-Golden M, 2007, N Engl J Med, 357, 1841, 10.1056/NEJMra071371
Lehnigk B, 1998, Eur Respir J, 11, 617, 10.1183/09031936.98.11030617
Tardif JC, 2010, Circ Cardiovasc Imaging, 3, 298, 10.1161/CIRCIMAGING.110.937169
Matsumoto S, 2017, Clin Cardiol, 40, 210, 10.1002/clc.22646
Gaztanaga J, 2015, Atherosclerosis, 240, 53, 10.1016/j.atherosclerosis.2015.02.027
Ericsson H, 2018, Clin Transl Sci, 11, 330, 10.1111/cts.12546
Dinarello CA., 2009, Annu Rev Immunol, 27, 519, 10.1146/annurev.immunol.021908.132612
Toldo S, 2017, JACC Basic Transl Sci, 2, 431, 10.1016/j.jacbts.2017.07.006
Abbate A, 2008, Circulation, 117, 2670, 10.1161/CIRCULATIONAHA.107.740233
Van Tassell BW, 2010, J Cardiovasc Pharmacol, 55, 117, 10.1097/FJC.0b013e3181c87e53
Abbate A, 2010, Am J Cardiol, 105, 1371, 10.1016/j.amjcard.2009.12.059
Abbate A, 2013, Am J Cardiol, 111, 1394, 10.1016/j.amjcard.2013.01.287
Abbate A, 2015, Am J Cardiol, 115, 288, 10.1016/j.amjcard.2014.11.003
Van Tassell BW, 2018, Clin Cardiol, 41, 1004, 10.1002/clc.22988
Tanaka T, 2014, Cold Spring Harb Perspect Biol, 6, a016295, 10.1101/cshperspect.a016295
Rubbert-Roth A, 2018, Rheumatol Ther, 5, 21, 10.1007/s40744-018-0102-x
Carroll MB, 2018, Mod Rheumatol, 28, 733, 10.1080/14397595.2018.1427457
Kleveland O, 2016, Eur Heart J, 37, 2406, 10.1093/eurheartj/ehw171
Carroll MB, 2018, Rheumatol Int, 38, 59, 10.1007/s00296-017-3842-y
Tang TT, 2012, Basic Res Cardiol, 107, 232, 10.1007/s00395-011-0232-6
Hofmann U, 2012, Circulation, 125, 1652, 10.1161/CIRCULATIONAHA.111.044164
Hartemann A, 2013, Lancet Diabetes Endocrinol, 1, 295, 10.1016/S2213-8587(13)70113-X
Soiffer RJ, 1992, Blood, 79, 517, 10.1182/blood.V79.2.517.517
Zhao TX, 2018, BMJ Open, 8, e022452, 10.1136/bmjopen-2018-022452
Capodanno D, 2018, Expert Opin Investig Drugs, 27, 997, 10.1080/13543784.2018.1543399
Gibson CM, 2016, Am Heart J, 180, 22, 10.1016/j.ahj.2016.06.017
Gille A, 2012, Circulation, 126, A11851
Michael Gibson C, 2016, Circulation, 134, 1918, 10.1161/CIRCULATIONAHA.116.025687
Gibson CM, 2019, Am Heart J, 208, 81, 10.1016/j.ahj.2018.11.008
Gurbel PA, 2018, J Thromb Thrombolysis, 45, 469, 10.1007/s11239-018-1644-z
Tardy C, 2014, Atherosclerosis, 232, 110, 10.1016/j.atherosclerosis.2013.10.018
Tardif JC, 2014, Eur Heart J, 35, 3277, 10.1093/eurheartj/ehu171
Kataoka Y, 2017, Cardiovasc Diagn Ther, 7, 252, 10.21037/cdt.2017.02.01
Nicholls SJ, 2018, JAMA Cardiol, 3, 815, 10.1001/jamacardio.2018.2121
Gualandri V, 1985, Am J Hum Genet, 37, 1083
Nissen SE, 2003, JAMA, 290, 2292, 10.1001/jama.290.17.2292
Kallend DG, 2016, Eur Heart J Cardiovasc Pharmacother, 2, 23, 10.1093/ehjcvp/pvv041
Reijers JAA, 2017, Cardiovasc Drugs Ther, 31, 381, 10.1007/s10557-017-6746-x
Nicholls SJ, 2018, JAMA Cardiol, 3, 806, 10.1001/jamacardio.2018.2112
Rousset X, 2011, Curr Atheroscler Rep, 13, 249, 10.1007/s11883-011-0171-6
Shamburek RD, 2016, Circ Res, 118, 73, 10.1161/CIRCRESAHA.115.306223
George RT, 2017, Circulation, 136, A14664
Chaudhary R, 2017, World J Cardiol, 9, 76, 10.4330/wjc.v9.i2.76
Rosenson RS, 2018, J Am Coll Cardiol, 72, 314, 10.1016/j.jacc.2018.04.054
Frank-Kamenetsky M, 2008, Proc Natl Acad Sci U S A, 105, 11915, 10.1073/pnas.0805434105
Meister G1, 2004, Nature, 431, 343, 10.1038/nature02873
Fitzgerald K, 2014, Lancet, 383, 60, 10.1016/S0140-6736(13)61914-5
Fitzgerald K, 2017, N Engl J Med, 376, 41, 10.1056/NEJMoa1609243
Ray KK, 2017, N Engl J Med, 376, 1430, 10.1056/NEJMoa1615758
Gurbel PA, 2015, Arterioscler Thromb Vasc Biol, 35, 500, 10.1161/ATVBAHA.114.303412
Gurbel PA, Jeong YH, Tantry US, 2011, Expert Opin Investig Drugs, 20, 1445, 10.1517/13543784.2011.606809
Zhang P, 2013, Platelets, 3, 249, 10.1016/B978-0-12-387837-3.00013-4
Flaumenhaft R, 2017, Trends Pharmacol Sci, 38, 701, 10.1016/j.tips.2017.05.001
Zhang P, 2012, Circulation, 126, 83, 10.1161/CIRCULATIONAHA.112.091918
Gurbel PA, 2016, Arterioscler Thromb Vasc Biol, 36, 189, 10.1161/ATVBAHA.115.306777
Thomas MR, 2016, Thromb Haemost, 116, 96, 10.1160/TH16-02-0102
Silvain J, 2016, Thromb Haemost, 116, 369, 10.1160/TH15-12-0944
Shan J, 2012, J Med Chem, 55, 3342, 10.1021/jm300038c
Li X, 2018, Front Pharmacol, 9, 643, 10.3389/fphar.2018.00643
Gurbel PA, 2019, Circulation, 139, 2170, 10.1161/CIRCULATIONAHA.118.033580
Shinozawa E, 2018, Front Pharmacol, 9, 1431, 10.3389/fphar.2018.01431
Goldstein S, 2014, Thromb Haemost, 111, 1141, 10.1160/TH13-07-0543
Lorant DE, 1993, J Clin Invest, 92, 559, 10.1172/JCI116623
Yazici M, 2005, Circ J, 69, 530, 10.1253/circj.69.530
Gurbel PA, 1998, Coron Artery Dis, 9, 451, 10.1097/00019501-199809070-00008
Tardif JC, 2013, J Am Coll Cardiol, 61, 2048, 10.1016/j.jacc.2013.03.003
Mojica Muñoz AK, 2017, Thromb Haemost, 117, 1651, 10.1160/TH16-11-0856
Ungerer M, 2011, Circulation, 123, 1891, 10.1161/CIRCULATIONAHA.110.980623
Schüpke S, 2019, Thromb Haemost
Lader AS, 2016, J Cardiovasc Pharmacol, 68, 241, 10.1097/FJC.0000000000000408
Kates SA, 2014, Basic Clin Pharmacol Toxicol, 115, 456, 10.1111/bcpt.12254
Krucoff MW, Ponde CK, Hiremath J, et al. A prospective randomized trial of CMX- 2043, a lipoic acid-based cytoprotectant, In Patients Undergoing Elective PCI: Primary Results of the SUPPORT-1. TCT 2012.
Bhatt DL, on behalf of the CARIN Investigators. A prospective, comparative, randomized, multi-center, double-blinded, placebo-controlled, phase 2a study of the safety and efficacy of CMX-2043 for periprocedural injury protection in subjects undergoing coronary angiography at risk of radio-contrast induced nephropathy. ACC 2016.
Ghosh GC, 2017, Cardiovasc Ther, 35, 4, 10.1111/1755-5922.12231
Tsujikawa LM, 2019, Clin Epigenetics, 11, 102, 10.1186/s13148-019-0696-z
Nicholls SJ, 2011, J Am Coll Cardiol, 57, 1111, 10.1016/j.jacc.2010.11.015
Nicholls SJ, 2012, Cardiovasc Drugs Ther, 26, 181, 10.1007/s10557-012-6373-5
Nicholls SJ, 2016, Am J Cardiovasc Drugs, 16, 55, 10.1007/s40256-015-0146-z
Nicholls SJ, 2018, Am J Cardiovasc Drugs, 18, 109, 10.1007/s40256-017-0250-3
Ma XL, 1999, Circulation, 99, 1685, 10.1161/01.CIR.99.13.1685
O’Donoghue ML, 2016, JAMA, 315, 1591, 10.1001/jama.2016.3609
Schulz R, 2007, Heart Fail Rev, 12, 261, 10.1007/s10741-007-9032-3
National Center for Biotechnology Information. PubChem Database. Danegaptide, CID=16656685, https://pubchem.ncbi.nlm.nih.gov/compound/Danegaptide
Skyschally A, 2013, Naunyn Schmiedebergs Arch Pharmacol, 386, 383, 10.1007/s00210-013-0840-9
Engstrøm T, 2018, Heart, 104, 1593, 10.1136/heartjnl-2017-312774
Paradies G, 2010, Free Radic Biol Med, 48, 1286, 10.1016/j.freeradbiomed.2010.02.020
Brown DA, 2014, J Cardiovasc Pharmacol Ther, 19, 121, 10.1177/1074248413508003
Kloner RA, 2012, J Am Heart Assoc, 1, e001644, 10.1161/JAHA.112.001644
Gibson CM, 2016, Eur Heart J, 37, 1296, 10.1093/eurheartj/ehv597
Navarese EP, 2016, Ann Intern Med, 164, 600, 10.7326/M15-2994
Ridker PM, 2017, N Engl J Med, 377, 1119, 10.1056/NEJMoa1707914
Bhatt DL, 2019, N Engl J Med, 380, 11, 10.1056/NEJMoa1812792
Ridker PM, 2019, N Engl J Med, 380, 752, 10.1056/NEJMoa1809798
